Health Care

Lilly wins approval for potential blockbuster drug

April 21, 2014
Bloomberg News
The Indianapolis-based pharmaceutical maker gets a much-needed boost with FDA approval for gastric-cancer drug ramucirumab, which quickly could account for $1 billion in annual sales.
More

Mainstreet aims to help finance nursing home through crowdfundingRestricted Content

April 19, 2014
J.K. Wall
Mainstreet Property Group LLC plans to launch a new round of private placement fundraising on April 21 using a website run by Oregon-based CrowdStreet Inc. and a mix of traditional advertising in central Indiana.
More

Late sign-ups boost numbers, improve Obamacare outlook

April 18, 2014
Associated Press
Still to be announced is what share of those 8 million enrollees were previously uninsured, and how many actually secured coverage by paying their first month's premiums.
More

Leaders await decision on Indiana Plan expansion

April 15, 2014
Associated Press
Two of the state's top Republican lawmakers said Tuesday that they would like to see the federal government sign off on an expansion of Medicaid through the state's health care plan for low-income residents.
More

Downtown Evansville picked for new IU med school

April 11, 2014
Associated Press
Evansville officials had pushed the location covering nearly six city blocks as a key for downtown redevelopment. The center that could draw some 2,000 health care students.
More

ANALYSIS: Turner stood to lose big in Statehouse fight

April 10, 2014
Associated Press analysis
A top Indiana lawmaker, his family and investors in their company risked losing millions in future profits if a proposed ban on construction of new nursing homes in Indiana had become law this year, an Associated Press review has found.
More

Indiana insurers must make best guesses on 2015 price hikes

April 10, 2014
J.K. Wall
Health insurers such as WellPoint Inc. that plan to hike prices on their Obamacare policies more than 10 percent in 2015 will have a much harder time than usual making their case to regulators.
More

WellPoint spending millions in California ballot battle

April 9, 2014
Bloomberg News
WellPoint Inc. is leading companies that have poured $13.4 million into defeating a ballot initiative that would give California regulators the power to reject increases in health policy premiums.
More

Lilly stock shows little impact from $3B court award

April 8, 2014
Eli Lilly and Co.’s stock showed little change Tuesday morning in the wake of a federal court decision that saw jurors order the company to pay a massive damage award related to its Actos diabetes medicine.
More

Ex-owner of troubled dental clinic pleads guilty to tax evasion

April 8, 2014
Associated Press
The former owner of a central Indiana dental clinic being investigated for Medicaid fraud has been sentenced to two years in federal prison for not paying more than $850,000 in taxes.
More

Lilly ordered to pay $3 billion in Actos damages

April 8, 2014
Bloomberg News
Takeda Pharmaceutical Co. and Eli Lilly and Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
More

Pfizer, Lilly drugs slow advanced breast cancer in studies

April 7, 2014
Bloomberg News
Pfizer Inc., Eli Lilly and Co. and Novartis AG have dug an idea out of the pharmaceutical dustbin to create new medicines that are showing blockbuster potential.
More

CarDon trying to adjust nursing homes to hospitals, insurers, patientsRestricted Content

April 5, 2014
J.K. Wall
Family-run company is building nursing homes it thinks will be more attractive to residents and staff.
More

IU Health doctors to do surgeries in WisconsinRestricted Content

April 5, 2014
J.K. Wall
Indiana University Health was chosen by a hospital system in Wisconsin to provide heart, lung, esophagus and aorta surgeries there after the surgeons the hospital system had been using became employed by a competing provider.
More

Patent ‘troll’ label gets Congress to ponder what’s in a name

April 2, 2014
Bloomberg News
"Troll" is a term without clear definition and yet it’s being used to push Congress and the Supreme Court to curb abusive litigation. Companies including Eli Lilly warn against damaging a centuries-old system designed to promote advances in science and industry.
More

Would-be Lilly foe wins U.S. panel backing for inhaled insulin

April 1, 2014
Bloomberg News
Advisers to the Food and Drug Administration voted 13-1 and 14-0 that the drug, Afrezza, should be approved for Type 1 and Type 2 diabetes, respectively. The FDA doesn’t have to follow the panel’s recommendation.
More

Indianapolis court backs patent for Lilly cancer drug Alimta

April 1, 2014
Associated Press
A federal court has upheld the patent that protects Eli Lilly and Co.'s lung-cancer treatment from generic competition until 2022.
More

Pence continues to seek repeal of medical device tax

March 31, 2014
 The Statehouse File
A number of Indiana lawmakers – including both of the state’s U.S. senators – have advocated for the elimination of the tax, in part because the state is home to several key medical device manufacturers.
More

Obamacare sign-ups on track to hit 7 million, sources say

March 31, 2014
Associated Press
The 7 million target, thought to be out of reach by most experts, was in sight on a day that saw surging consumer interest as well as vexing computer glitches.
More

Deadline brings crush of Indiana health coverage applicants

March 31, 2014
Associated Press
The last-minute flood of applicants in Indiana mirrored national trends as people sought to at least start the process Monday.
More

IU Health suffers small decline in 2013 profit

March 31, 2014
J.K. Wall
Indiana University Health’s business deteriorated last year in nearly every area. But price hikes and a surge in outpatient visits to Indianapolis-area facilities mostly offset those problems.
More

Cancer treatment makes Endocyte premium takeover target

March 28, 2014
Bloomberg News
Now that Indiana-based Endocyte Inc.’s experimental cancer treatment is proving successful, the company may command a takeover bid at one of the industry’s highest premiums on record.
More

Would-be Lilly competitor's inhaled insulin tied to lung concerns

March 28, 2014
Bloomberg News
Afrezza, a powdered insulin used through an inhaler, would be the MannKind Corp.'s first marketed product. The treatment would compete against Lilly's Humalog. An FDA report tied the drug to a decline in lung function.
More

Obama says more than 6M signed up for health care

March 27, 2014
Associated Press
Like much else about Obama's health care law, the milestone comes with a caveat: The administration has yet to announce how many consumers actually closed the deal by paying their first month's premium.
More

Feds grant extra time to enroll for Obamacare

March 26, 2014
Associated Press
People who've started applying for health insurance but aren't able to finish before the March 31 enrollment deadline will get extra time, the Obama administration announced Tuesday.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. With Pence running the ship good luck with a new government building on the site. He does everything on the cheap except unnecessary roads line a new beltway( like we need that). Things like state of the art office buildings and light rail will never be seen as an asset to these types. They don't get that these are the things that help a city prosper.

  2. Does the $100,000,000,000 include salaries for members of Congress?

  3. "But that doesn't change how the piece plays to most of the people who will see it." If it stands out so little during the day as you seem to suggest maybe most of the people who actually see it will be those present when it is dark enough to experience its full effects.

  4. That's the mentality of most retail marketers. In this case Leo was asked to build the brand. HHG then had a bad sales quarter and rather than stay the course, now want to go back to the schlock that Zimmerman provides (at a considerable cut in price.) And while HHG salesmen are, by far, the pushiest salesmen I have ever experienced, I believe they are NOT paid on commission. But that doesn't mean they aren't trained to be aggressive.

  5. The reason HHG's sales team hits you from the moment you walk through the door is the same reason car salesmen do the same thing: Commission. HHG's folks are paid by commission they and need to hit sales targets or get cut, while BB does not. The sales figures are aggressive, so turnover rate is high. Electronics are the largest commission earners along with non-needed warranties, service plans etc, known in the industry as 'cheese'. The wholesale base price is listed on the cryptic price tag in the string of numbers near the bar code. Know how to decipher it and you get things at cost, with little to no commission to the sales persons. Whether or not this is fair, is more of a moral question than a financial one.

ADVERTISEMENT